Protagonist Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Protagonist Therapeutics Inc
TickerPTGX
CIK #0001377121
CUSIP74366E102
SectorLife Sciences - Pharmaceutical Preparations
Address521 Cottonwood Drive, Suite 100, Malpitas, CA 95035-7404
Source [EDGAR]
CIK Filing 2011 - 2025
[0001377121] 10-K
[0001377121] 10-Q
[0001377121] 3
[0001377121] 4
[0001377121] 5
[0001377121] 8-K
[0001377121] D
[0001377121] SC 13D
[0001377121] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Protagonist Therapeutics Inc [2025-08-11] 0.0
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2025-06-16] 0.0
State Street Corp Protagonist Therapeutics Inc [2025-05-13] 0.0
Deep Track Capital LP Protagonist Therapeutics Inc [2025-04-10] 0.0
State Street Corp Protagonist Therapeutics Inc [2024-10-16] 5.4
Point72 Asset Management LP Protagonist Therapeutics Inc [2023-12-18] 5.5
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2023-04-13] 5.44
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2023-03-20] 5.1
Vanguard Group Inc Protagonist Therapeutics Inc [2023-02-09] 6.3
Citadel Advisors LLC Protagonist Therapeutics Inc [2023-01-03] 3.6
State Street Corp Protagonist Therapeutics Inc [2022-02-10] 5.39
Point72 Asset Management LP Protagonist Therapeutics Inc [2021-09-21] 0.1
Consonance Capital Management LP Protagonist Therapeutics Inc [2021-02-17] 5.75
Consonance Capital Management LP Protagonist Therapeutics Inc [2021-02-16] 5.75
BlackRock Inc Protagonist Therapeutics Inc [2021-02-02] 6.2
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2020-05-22] 6.39
BlackRock Inc Protagonist Therapeutics Inc [2020-02-07] 5.7
RTW Investments LP Protagonist Therapeutics Inc [2019-12-16] 8.04
Integrated Core Strategies US LLC Protagonist Therapeutics Inc [2019-07-01] 3.5
Venrock Healthcare Capital Partners II LP Protagonist Therapeutics Inc [2019-06-17] 6.4
Perceptive Advisors LLC Protagonist Therapeutics Inc [2018-12-10] 5.3
Farallon Capital Management LLC Protagonist Therapeutics Inc [2018-08-20] 1.9
Great Point Partners LLC Protagonist Therapeutics Inc [2018-07-02] 6.95
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2018-05-24] 3.4
Pharmstandard International Sa Protagonist Therapeutics Inc [2017-02-13] 5.88
Canaan X LP Protagonist Therapeutics Inc [2017-01-26] 14.7
FMR LLC Protagonist Therapeutics Inc [2016-10-11] 0.0
Aisling Capital IV LP Protagonist Therapeutics Inc [2016-09-12] 5.1
Lilly Ventures Fund I LLC Protagonist Therapeutics Inc [2016-08-26] 12.9
RA Capital Management LLC Protagonist Therapeutics Inc [2016-08-25] 6.8
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2016-08-19] 0.69
Johnson & Johnson Protagonist Therapeutics Inc [2016-08-19] 15.0
Form 3/4/5 Filer 2011 - 2025
Protagonist Therapeutics, Inc
Patel Dinesh V Ph D
Molina Arturo MD
Selick Harold E
Ali Asif
Waddill William D.
O'Dowd Sarah A
Williams Lewis T
Giraudo Bryan
Gupta Suneel
Swisher Daniel N JR
Noonberg Sarah B.
Liu David Y
Kalkofen Donald A.
Saks Samuel R
Khosla Chaitan PhD
Shames Richard S.
Murphy Niall
O'Neil Thomas P.
Shanafelt Armen
Canaan Partners X LLC
Canaan X LP
Adage Capital Advisors, L.L.C.
Adage Capital Partners, L.P.
Adage Capital Partners GP LLC
Atchinson Robert
Gross Phillip
Grant Julie Papanek
Hodder William A
Johnson & Johnson
Johnson & Johnson Innovation - JJDC, Inc.
Lilly Ventures Fund I LLC
Torres S. Edward
Hall Steven Edward
LV Management Group, LLC
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 9,482,436 9,630,341
Farallon Capital Management LLC [2025-06-30] OTR 6,172,006 6,172,006
RTW Investments LP [2025-06-30] SOLE 5,756,277 5,756,277
Vanguard Group Inc [2025-06-30] SOLE 0 4,234,689
Deep Track Capital LP [2025-06-30] SOLE 3,245,899 3,245,899
BVF Inc/IL [2025-06-30] DFND 0 3,211,041
State Street Corp [2025-06-30] DFND 3,059,580 3,207,543
UBS Group AG [2025-06-30] DFND 2,500,942 2,501,251
Johnson & Johnson [2025-06-30] DFND 0 2,449,183
Geode Capital Management LLC [2025-06-30] DFND 1,444,230 1,444,230
Adage Capital Partners GP LLC [2025-06-30] SOLE 1,092,262 1,092,262
Commodore Capital LP [2025-06-30] SOLE 1,075,000 1,075,000
Perceptive Advisors LLC [2025-06-30] SOLE 1,074,448 1,074,448
Wellington Management Group LLP [2025-06-30] DFND 0 1,037,738
Adar1 Capital Management LLC [2025-06-30] SOLE 948,069 948,069
Woodline Partners LP [2025-06-30] SOLE 946,884 946,884
Morgan Stanley [2025-06-30] DFND 827,693 868,963
Bank of America Corp /DE/ [2025-06-30] DFND 18,448 851,832
Jefferies Financial Group Inc. [2025-06-30] DFND 824,019 824,019
American Century Companies Inc [2025-06-30] DFND 737,097 813,995
Goldman Sachs Group Inc [2025-06-30] DFND 761,681 767,068
Driehaus Capital Management LLC [2025-06-30] SOLE 586,206 757,710
Pictet Asset Management Holding SA [2025-06-30] SOLE 680,197 751,977
Lynx1 Capital Management LP [2025-06-30] OTR 0 733,014
Invesco Ltd. [2025-06-30] DFND 0 721,680
Northern Trust Corp [2025-06-30] DFND 581,230 582,998
Charles Schwab Investment Management Inc [2025-06-30] SOLE 575,320 575,364
FMR LLC [2025-06-30] DFND 534,369 538,432
Holocene Advisors LP [2025-06-30] SOLE 530,326 530,326
Janus Henderson Group PLC [2025-06-30] DFND 0 446,828
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com